{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T04:23:08Z","timestamp":1793506988348,"version":"4.5.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.bioorg.2024.107936","type":"journal-article","created":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T21:40:08Z","timestamp":1730842808000},"page":"107936","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Eco-conscious synthesis of novel 1,2,4-triazolo[1,5-a]pyrimidine derivatives as potent Anti-microbial agent and comparative study of cell viability and cytotoxicity in HEK-293 cell line utilizing Indian gooseberry (Phyllanthus emblica) fruit extract"],"prefix":"10.1016","volume":"153","author":[{"given":"Bhaktiben R.","family":"Bhatt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamalkishor","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarosh","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anupama","family":"Modi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandani","family":"Halpani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vaibhav D.","family":"Bhatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bharat C.","family":"Dixit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2024.107936_b0005","unstructured":"Organization, W.H., Antimicrobial resistance. 2022: World Health Organization."},{"issue":"3","key":"10.1016\/j.bioorg.2024.107936_b0010","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1021\/np200906s","article-title":"Natural products as sources of new drugs over the 30 years from 1981 to 2010","volume":"75","author":"Newman","year":"2012","journal-title":"J. Nat. Prod."},{"issue":"8","key":"10.1016\/j.bioorg.2024.107936_b0015","first-page":"155","article-title":"Amalaki (Emblica officinalis Gaertn.): A review on its therapeutic properties. Journal of Ayurveda and Integrated Medical","volume":"8","author":"Yadav","year":"2023","journal-title":"Sciences"},{"issue":"13","key":"10.1016\/j.bioorg.2024.107936_b0020","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1002\/cssc.201900351","article-title":"Broadening the scope of biocatalysis in sustainable organic synthesis","volume":"12","author":"Sheldon","year":"2019","journal-title":"ChemSusChem"},{"issue":"10","key":"10.1016\/j.bioorg.2024.107936_b0025","doi-asserted-by":"crossref","first-page":"821","DOI":"10.2174\/0115701786291084240206113913","article-title":"Recent Advances in Biginelli Reaction using Nanoparticles, Zeolites and Metal Compounds as Catalyst: A Concise Review","volume":"21","author":"Bhatt","year":"2024","journal-title":"Lett. Org. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2024.107936_b0030","article-title":"Significance and biological importance of pyrimidine in the microbial world","volume":"2014","author":"Sharma","year":"2014","journal-title":"International Journal of Medicinal Chemistry"},{"issue":"5","key":"10.1016\/j.bioorg.2024.107936_b0035","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1039\/D0RA08189B","article-title":"Synthesis and antimicrobial activity of some novel 1, 2-dihydro-[1, 2, 4] triazolo [1, 5-a] pyrimidines bearing amino acid moiety","volume":"11","author":"Mohamed","year":"2021","journal-title":"RSC Adv."},{"issue":"10","key":"10.1016\/j.bioorg.2024.107936_b0040","doi-asserted-by":"crossref","first-page":"4194","DOI":"10.1021\/jm501831g","article-title":"Synthesis and evaluation of 1, 2, 4-triazolo [1, 5-a] pyrimidines as antibacterial agents against Enterococcus faecium","volume":"58","author":"Wang","year":"2015","journal-title":"J. Med. Chem."},{"issue":"8","key":"10.1016\/j.bioorg.2024.107936_b0045","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.3987\/COM-07-11060","article-title":"Synthesis and Antimicrobial Evaluation of Novel Pyrazolo (1, 5-a) pyrimidine, Triazolo (1, 5-a) pyrimidine and Pyrimido (1, 2-a) benzimidazole Derivatives","volume":"71","author":"Shaaban","year":"2007","journal-title":"Heterocycles"},{"key":"10.1016\/j.bioorg.2024.107936_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.104841","article-title":"Design, synthesis and mechanistic study of new 1, 2, 4-triazole derivatives as antimicrobial agents","volume":"111","author":"Amin","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2024.107936_b0055","doi-asserted-by":"crossref","unstructured":"Anastas, P.T. and J.C. Warner, Green chemistry: theory and practice. 2000: Oxford university press.","DOI":"10.1093\/oso\/9780198506980.001.0001"},{"issue":"1","key":"10.1016\/j.bioorg.2024.107936_b0060","first-page":"134","article-title":"Drug resistance in Chromobacterium violaceum","volume":"3","author":"Fantinatti-Garboggini","year":"2004","journal-title":"Genet Mol Res"},{"issue":"4","key":"10.1016\/j.bioorg.2024.107936_b0065","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1128\/CMR.11.4.589","article-title":"Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors","volume":"11","author":"Podschun","year":"1998","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.bioorg.2024.107936_b0070","unstructured":"Curtiss, R. and F.C. Neidhardt, Escherichia coli and Salmonella: cellular and molecular biology. 1996: ASM Press."},{"issue":"8","key":"10.1016\/j.bioorg.2024.107936_b0075","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1056\/NEJM199808203390806","article-title":"Staphylococcus aureus infections","volume":"339","author":"Lowy","year":"1998","journal-title":"N. Engl. J. Med."},{"issue":"6072","key":"10.1016\/j.bioorg.2024.107936_b0080","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1126\/science.1206848","article-title":"Condition-dependent transcriptome reveals high-level regulatory architecture in Bacillus subtilis","volume":"335","author":"Nicolas","year":"2012","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.bioorg.2024.107936_b0085","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ram.2022.08.003","article-title":"Candida albicans the main opportunistic pathogenic fungus in humans","volume":"55","author":"Macias-Paz","year":"2023","journal-title":"Revista Argentina De Microbiolog\u00eda"},{"issue":"3","key":"10.1016\/j.bioorg.2024.107936_b0090","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/nrmicro2522","article-title":"Expanding fungal pathogenesis: Cryptococcus breaks out of the opportunistic box","volume":"9","author":"Kronstad","year":"2011","journal-title":"Nat. Rev. Microbiol."},{"issue":"6","key":"10.1016\/j.bioorg.2024.107936_b0095","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1101\/gr.112169.110","article-title":"Comparative genomics of citric-acid-producing Aspergillus niger ATCC 1015 versus enzyme-producing CBS 513.88","volume":"21","author":"Andersen","year":"2011","journal-title":"Genome Res."},{"issue":"3","key":"10.1016\/j.bioorg.2024.107936_b0100","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.vascn.2004.08.014","article-title":"HEK293 cell line: a vehicle for the expression of recombinant proteins","volume":"51","author":"Thomas","year":"2005","journal-title":"J. Pharmacol. Toxicol. Methods"},{"issue":"3","key":"10.1016\/j.bioorg.2024.107936_b0105","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1128\/MMBR.00016-10","article-title":"Origins and evolution of antibiotic resistance","volume":"74","author":"Davies","year":"2010","journal-title":"Microbiol. Mol. Biol. Rev."},{"issue":"3","key":"10.1016\/j.bioorg.2024.107936_b0110","doi-asserted-by":"crossref","DOI":"10.5395\/rde.2021.46.e36","article-title":"Comparative evaluation of Emblica officinalis as an etchant and an MMP inhibitor with orthophosphoric acid and chlorhexidine on the microshear bond strength of composite resin: an ex vivo study","volume":"46","author":"Rajkumar","year":"2021","journal-title":"Restorative Dentistry & Endodontics"},{"issue":"2","key":"10.1016\/j.bioorg.2024.107936_b0115","first-page":"5","article-title":"Indian gooseberry (Emblica officinalis): Complete pharmacognosy review","volume":"2","author":"Kulkarni","year":"2018","journal-title":"International Journal of Chemistry Studies"},{"issue":"19","key":"10.1016\/j.bioorg.2024.107936_b0120","doi-asserted-by":"crossref","first-page":"11083","DOI":"10.1039\/D1RA00392E","article-title":"\u03b1-Aminoazoles\/azines: key reaction partners for multicomponent reactions","volume":"11","author":"Imtiaz","year":"2021","journal-title":"RSC Adv."},{"issue":"9","key":"10.1016\/j.bioorg.2024.107936_b0125","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1136\/jcp.24.9.779","article-title":"A study of antibiotic sensitivity testing with proposals for simple uniform methods","volume":"24","author":"Garrod","year":"1971","journal-title":"J. Clin. Pathol."},{"issue":"8","key":"10.1016\/j.bioorg.2024.107936_b0130","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.3390\/molecules21081072","article-title":"Synthesis and antimicrobial activity of some new thiadiazoles, thioamides, 5-arylazothiazoles and pyrimido [4, 5-d][1, 2, 4] triazolo [4, 3-a] pyrimidines","volume":"21","author":"Abdelhamid","year":"2016","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.bioorg.2024.107936_b0135","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/nprot.2007.521","article-title":"Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances","volume":"3","author":"Wiegand","year":"2008","journal-title":"Nat. Protoc."},{"issue":"9","key":"10.1016\/j.bioorg.2024.107936_b0140","article-title":"Successful Treatment of Chromobacterium violaceum in a North Indian Adult: A Case Report with Review of Literature","volume":"13","author":"Nayyar","year":"2019","journal-title":"J. Clin. Diagn. Res."},{"key":"10.1016\/j.bioorg.2024.107936_b0145","unstructured":"Freshney, R.I., Culture of animal cells: a manual of basic technique and specialized applications. 2015: John Wiley & Sons."},{"key":"10.1016\/j.bioorg.2024.107936_b0150","first-page":"64","article-title":"In vitro cytotoxicity and cell viability assays: principles, advantages, and disadvantages","volume":"2","author":"Aslant\u00fcrk","year":"2018","journal-title":"Genotoxicity-A Predictable Risk to Our Actual World"},{"issue":"2","key":"10.1016\/j.bioorg.2024.107936_b0155","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/pst.426","article-title":"Guidelines for accurate EC50\/IC50 estimation","volume":"10","author":"Sebaugh","year":"2011","journal-title":"Pharm. Stat."},{"issue":"3","key":"10.1016\/j.bioorg.2024.107936_b0160","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/nrd3373","article-title":"Cell death assays for drug discovery","volume":"10","author":"Kepp","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"issue":"5","key":"10.1016\/j.bioorg.2024.107936_b0165","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1021\/ci049794h","article-title":"Personal experience with four kinds of chemical structure drawing software: review on ChemDraw, ChemWindow, ISIS\/Draw, and ChemSketch","volume":"44","author":"Li","year":"2004","journal-title":"J. Chem. Inf. Comput. Sci."},{"key":"10.1016\/j.bioorg.2024.107936_b0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1758-2946-3-33","article-title":"Open Babel: An open chemical toolbox","volume":"3","author":"O'Boyle","year":"2011","journal-title":"J. Cheminf."},{"issue":"7","key":"10.1016\/j.bioorg.2024.107936_b0175","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1021\/jm0306430","article-title":"Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy","volume":"47","author":"Friesner","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107936_b0180","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10822-013-9644-8","article-title":"Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments","volume":"27","author":"Madhavi Sastry","year":"2013","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.bioorg.2024.107936_b0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmgm.2020.107730","article-title":"Targeting the SARS-CoV-2 main protease using FDA-approved Isavuconazonium, a P2\u2013P3 \u03b1-ketoamide derivative and Pentagastrin: An in-silico drug discovery approach","volume":"101","author":"Achilonu","year":"2020","journal-title":"J. Mol. Graph. Model."},{"key":"10.1016\/j.bioorg.2024.107936_b0190","unstructured":"Biovia, D.S., Discovery studio modeling environment. 2017, Release."},{"issue":"11","key":"10.1016\/j.bioorg.2024.107936_b0195","doi-asserted-by":"crossref","first-page":"e0294511","DOI":"10.1371\/journal.pone.0294511","article-title":"Computational exploration of novel ROCK2 inhibitors for cardiovascular disease management; insights from high-throughput virtual screening, molecular docking, DFT and MD simulation","volume":"18","author":"Ali","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.bioorg.2024.107936_b0200","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/978-1-4939-7366-8_4","article-title":"YASARA: a tool to obtain structural guidance in biocatalytic investigations","volume":"1685","author":"Land","year":"2018","journal-title":"Protein Engineering: Methods and Protocols"},{"key":"10.1016\/j.bioorg.2024.107936_b0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/07391102.2023.2294385","article-title":"In-silico design, pharmacophore-based screening, and molecular docking studies reveal that benzimidazole-1, 2, 3-triazole hybrids as novel EGFR inhibitors targeting lung cancer","author":"Kumar","year":"2023","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.bioorg.2024.107936_b0210","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1007\/s00044-011-9719-9","article-title":"Homology modeling, molecular dynamics, and molecular docking studies of Trichomonas vaginalis carbamate kinase","volume":"21","author":"Kirubakaran","year":"2012","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.bioorg.2024.107936_b0215","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s10822-012-9575-9","article-title":"Docking performance of the glide program as evaluated on the Astex and DUD datasets: a complete set of glide SP results and selected results for a new scoring function integrating WaterMap and glide","volume":"26","author":"Repasky","year":"2012","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.bioorg.2024.107936_b0220","first-page":"1","article-title":"In-silico identification and exploration of small molecule coumarin-1, 2, 3-triazole hybrids as potential EGFR inhibitors for targeting lung cancer","author":"Kumar","year":"2024","journal-title":"Mol. Divers."},{"issue":"7","key":"10.1016\/j.bioorg.2024.107936_b0225","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1021\/np0200616","article-title":"Natural products inhibiting Candida albicans secreted aspartic proteases from Lycopodium cernuum","volume":"65","author":"Zhang","year":"2002","journal-title":"J. Nat. Prod."},{"issue":"01","key":"10.1016\/j.bioorg.2024.107936_b0230","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1055\/s-2002-20049","article-title":"Natural products inhibiting Candida albicans secreted aspartic proteases from Tovomita krukovii","volume":"68","author":"Zhang","year":"2002","journal-title":"Planta Med."},{"issue":"96","key":"10.1016\/j.bioorg.2024.107936_b0235","doi-asserted-by":"crossref","first-page":"13535","DOI":"10.1039\/C8CC07810F","article-title":"Novel non-peptidic small molecule inhibitors of secreted aspartic protease 2 (SAP2) for the treatment of resistant fungal infections","volume":"54","author":"Dong","year":"2018","journal-title":"Chem. Commun."},{"issue":"3","key":"10.1016\/j.bioorg.2024.107936_b0240","doi-asserted-by":"crossref","first-page":"793","DOI":"10.3390\/biomedicines11030793","article-title":"Identification of natural lead compounds against hemagglutinin-esterase surface glycoprotein in human coronaviruses investigated via MD simulation, principal component analysis, cross-correlation, H-bond plot and MMGBSA","volume":"11","author":"Ali","year":"2023","journal-title":"Biomedicines"},{"issue":"17","key":"10.1016\/j.bioorg.2024.107936_b0245","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1080\/08927022.2023.2256624","article-title":"In-silico and in-vitro identification of triazole based compounds as potential EGFR inhibitors targeting lung cancer","volume":"49","author":"Kumar","year":"2023","journal-title":"Mol. Simul."},{"issue":"1","key":"10.1016\/j.bioorg.2024.107936_b0250","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s40203-023-00157-1","article-title":"In-silico identification of small molecule benzofuran-1, 2, 3-triazole hybrids as potential inhibitors targeting EGFR in lung cancer via ligand-based pharmacophore modeling and molecular docking studies","volume":"11","author":"Kumar","year":"2023","journal-title":"In Silico Pharmacol."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206824008411?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206824008411?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T21:28:15Z","timestamp":1738186095000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206824008411"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":50,"alternative-id":["S0045206824008411"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2024.107936","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Eco-conscious synthesis of novel 1,2,4-triazolo[1,5-a]pyrimidine derivatives as potent Anti-microbial agent and comparative study of cell viability and cytotoxicity in HEK-293 cell line utilizingIndian gooseberry (Phyllanthus emblica) fruit extract","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2024.107936","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107936"}}